Home Regulation & Policy Drug Safety in the Post-Vioxx Era:New legislation, regulation...
Info: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.
Regulation & Policy Drug Safety in the Post-Vioxx Era:New legislation, regulation...
Drug Safety in the Post-Vioxx Era:New legislation, regulation...
Price:
$2 875.00
Full Title: Drug Safety in the Post-Vioxx Era: New legislation, regulation and company strategies in Europe and the US
Executive Summary
The new report, Drug Safety in the Post-Vioxx Era: New legislation, regulation and company strategies in Europe and the US, examines the actions taken by legislative and regulatory bodies in response to recent drug safety concerns surrounding the COX-2 inhibitors and antidepressants. The report also analyzes the different management, marketing and technological strategies companies are pursuing to ensure the safety of their products, and provides predictions for the future of drug safety regulation in the US and EU.
